The US Government keeps an online database, at clinicaltrials.gov, of clinical research studies for Mesothelioma cancer, but doesn't review or approve the safety and science of these trials. The website is maintained by the National Library of Medicine (NLM). The links below go to the clinical trial information on clinicaltrials.gov. Talk with your health care professional about possible risks and benefits before joining any studies.
Fri, 13 Jun 2025 00:00:00 EDT
Conditions: Mesothelioma; Neoplasms; Stomach Neoplasms; Pancreatic Neoplasms; Ovarian Neoplasms; Lung Neoplasms; Thymus Neoplasms; Colonic Neoplasms
Interventions: Device: mesothelin expression testing; Biological: TNhYP217 CAR T Cells; Drug: fludarabine; Drug: cyclophosphamide
Sponsors: National Cancer Institute (NCI)
Not yet recruiting
Fri, 13 Jun 2025 00:00:00 EDT
Conditions: Mesothelioma; Malignant Mesothelioma (MM); Early-stage Mesothelioma; Subclinical Mesothelioma; BRCA1-Associated Protein-1 (BAP1) Mutations; Early-stage BAP1-associated Malignancies
Interventions: Drug: alrizomadlin
Sponsors: National Cancer Institute (NCI)
Not yet recruiting
Thu, 5 Jun 2025 00:00:00 EDT
Conditions: Mesothelioma; Mesotheliomas Pleural; Mesothelioma; Lung
Interventions: Other: Translation analysis
Sponsors: Istituto Oncologico Veneto IRCCS
Recruiting
Wed, 4 Jun 2025 00:00:00 EDT
Conditions: Malignant Mesothelioma; Metastatic Malignant Solid Tumor; Advanced Solid Tumor
Interventions: Drug: ISM6331
Sponsors: InSilico Medicine Hong Kong Limited
Recruiting
Wed, 11 Jun 2025 00:00:00 EDT
Conditions: Unresectable Pleural Mesothelioma
Interventions: Drug: Volrustomig; Drug: Pemetrexed; Drug: Carboplatin; Drug: Cisplatin; Drug: Nivolumab; Drug: Ipilimumab
Sponsors: AstraZeneca
Recruiting
Sun, 8 Jun 2025 00:00:00 EDT
Conditions: Malignant Peritoneal Mesothelioma; Peritoneal Mesothelioma; Mesothelioma; Mesothelioma, Malignant; Malignant Mesothelioma
Interventions: Drug: Pemetrexed; Drug: Cisplatin; Drug: Carboplatin
Sponsors: Memorial Sloan Kettering Cancer Center
Recruiting
Fri, 6 Jun 2025 00:00:00 EDT
Conditions: Mesothelioma; Malignant Mesothelioma (MM); Early-stage Mesothelioma; Subclinical Mesothelioma; BRCA1-Associated Protein-1 (BAP1) Mutations; Early-stage BAP1-associated Malignancies
Interventions: Drug: Decitabine/cedazuridine
Sponsors: National Cancer Institute (NCI)
Recruiting
Sun, 8 Jun 2025 00:00:00 EDT
Conditions: Neoplasms; Prostatic Neoplasms, Castration-Resistant; Stomach Neoplasms; Esophageal Neoplasms; Head and Neck Neoplasms; Colorectal Neoplasms; Pancreatic Neoplasms; Lung Neoplasms; Urinary Bladder Neoplasms; Mesothelioma, Malignant; Uterine Cervical Neoplasms; Kidney Neoplasms; Sarcoma; Pheochromocytomas
Interventions: Drug: HTL0039732 Capsules; Drug: HTL0039732 Capsules and atezolizumab infusion
Sponsors: Cancer Research UK; Nxera Pharma UK Limited
Recruiting
Wed, 11 Jun 2025 00:00:00 EDT
Conditions: Advanced Renal Cell Carcinoma; Advanced Mesothelioma; Advanced Osteosarcoma
Interventions: Drug: CAR.70/IL15-transduced CB-derived NK cells; Drug: Fludarabine phosphate; Drug: Cyclophosphamide
Sponsors: M.D. Anderson Cancer Center
Recruiting
Thu, 5 Jun 2025 00:00:00 EDT
Conditions: High Grade Epithelial Ovarian Cancer; High Grade Serous Ovarian Cancer; Primary Peritoneal Carcinoma; Fallopian Tube Cancer; Endometrial Cancer; Non-small Cell Lung Cancer; Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer (NSCLC); Mesothelioma; Breast Adenocarcinoma; Triple Negative Breast Cancer; Hormone Receptor-positive/Her2 Negative Breast Cancer; Platinum-resistant Ovarian Cancer (PROC); Platinum Sensitive Ovarian Cancer (PSOC); Primary Refractory Ovarian Cancer; Uterine Cancer
Interventions: Drug: Rina-S; Drug: Carboplatin; Drug: Bevacizumab; Drug: Pembrolizumab
Sponsors: Genmab
Recruiting
Menu